UTILITY OF APIXABAN OR RIVAROXABAN ANTI-XA LEVELS IN TRANSITIONING PATIENTS TO HEPARIN INFUSIONS
CRITICAL CARE MEDICINE（2022）
摘要
Critical Care Medicine: January 2022 - Volume 50 - Issue 1 - p 447 doi: 10.1097/01.ccm.0000809932.66896.2e
更多查看译文
关键词
heparin,apixaban
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要